Valuentum Exclusive Analysis for the Discerning Investor

Symbol Keyword

Member Login Email Password Join Now Forgotten Password Newsletters/Portfolios View Current and Archived Dividend Growth Newsletters View Current and Archived Best Ideas Newsletters Valuentum's Dividend Growth Newsletter Portfolio Valuentum's Best Ideas Newsletter Portfolio Order the Exclusive Publication! View Current and Archived Exclusive Editions Order the High Yield Dividend Newsletter! Dividend Cushion Efficacy Calculation Dividend-Adjusted Leverage White Paper Stock Screens How to Filter Data in Microsoft Excel Like a Pro Download Weekly Stock Screener (xls) -- login required The Quarterly DataScreener Products & Tools Financial Advisor (GOLD LEVEL) Publications DCF Valuation Model Template Order Value Trap Order Value Trap, second edition Value Trap Order PDF Copy Order Paperback Copy Presentation BookLife Review BlueInk Review Foreword Review Readers' Favorite Review Axiom Bronze Praise The Buying Index, VBI Value and Momentum Within Stocks, Too (2017) The Case for the Valuentum Style of Investing (2012) Investing's Odd Couple: Value and Momentum (2013) Stock-Selection Methodology, the Valuentum Buying Index (2011) Why Valuentum Buying Index Ratings Matter (2014) Dividend Changes Dividend Increases/Decreases for the Week of November 8 Dividend Increases/Decreases for the Week of November 1 Dividend Increases/Decreases for the Week of October 25 Dividend Increases/Decreases for the Week of October 18 Dividend Increases/Decreases for the Week of October 11 Dividend Increases/Decreases for the Week of October 4

Results 51 - 60 of 132 for mye. (0.22 seconds) Oncology News a Key Driver of Big Pharma Image Source: Images Money. Oncology product... Big Pharma 1Q Earnings Roundup, Part II Image Source: Paw Paw. Let’s take a look at... What Gilead’s Patent Miscue Means for Shareholders Image Source: Gilead. Not much…right now, but... Dividend Increases/Decreases for the Week Ending December 9 Let's take a look at companies raising/lowering... Gilead Sciences Continues Its Meltdown Image Source: Gilead. Valuentum has been out of... In the News: GE, O, EGO, CELG There is a lot happening in the markets. Let’s have... Our Reports on the Health Care Bellwethers Industry Our reports on the Health Care Bellwethers industry can... Celgene: A Hemeoncology Powerhouse Let’s walk through the investment merits of one of... Johnson & Johnson's Oncology Division A Force to Be Reckoned With Image Source: Open Grid Scheduler. Healthcare and... First Quarter 2017 Comes To A Close “Be sure to continue to study the difference... prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | next